Ann Arbor, MI, United States of America

Jiantao Hu

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Jiantao Hu

Introduction: Jiantao Hu is an accomplished inventor based in Ann Arbor, MI, with a significant portfolio of six patents. His work primarily focuses on developing pharmaceutical compounds aimed at treating serious health conditions, particularly cancer.

Latest Patents: Among his latest innovations, Jiantao Hu has developed two notable patents. The first involves "Fused 1,4-oxazepines as BET protein degraders." This patent presents compounds represented by a specific formula, which are designed to treat conditions responsive to the degradation of BET bromodomains, such as cancer. The second patent is centered on "MDM2 protein degraders," where compounds are again represented by a defined formula, targeting the degradation of the MDM2 protein to address various cancer-related disorders.

Career Highlights: Jiantao Hu's career is marked by his position at the University of Michigan, where he has been integral to the research and development of novel therapeutic solutions. His commitment to innovation in the field of biochemistry has significantly contributed to advancing cancer treatment options.

Collaborations: Throughout his career, Jiantao has collaborated with esteemed colleagues, including Shaomeng Wang and Fuming Xu. These collaborations highlight the importance of teamwork in driving research forward and achieving breakthroughs in scientific discoveries.

Conclusion: Jiantao Hu stands out as a prominent inventor whose innovative work in the realm of pharmaceuticals is shaping the future of cancer treatment. With his ongoing research and development efforts at the University of Michigan, his contributions continue to impact the scientific community and offer hope to many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…